Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Taro Pharmaceutical Industries Ltd (NYSE:TARO)

106.73
Delayed Data
As of Dec 13
 +0.74 / +0.70%
Today’s Change
94.00
Today|||52-Week Range
128.46
+1.39%
Year-to-Date
No recent news for Taro Pharmaceutical Industries Ltd.

Today’s Trading

Previous close105.99
Today’s open106.48
Day’s range105.90 - 107.69
Volume91,775
Average volume (3 months)136,677
Market cap$4.3B
Data as of 4:00pm ET, 12/13/2017

Growth & Valuation

Earnings growth (last year)-12.51%
Earnings growth (this year)-14.10%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-7.51%
P/E ratio13.1
Price/Sales5.48
Price/Book2.08

Competitors

 Today’s
change
Today’s
% change
AGNPRAAllergan plc-10.05-1.63%
ACADACADIA Pharmaceutica...+0.76+2.60%
AKRXAkorn Inc+0.02+0.06%
MNKMallinckrodt Plc-0.20-0.83%
Data as of 4:02pm ET, 12/13/2017

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$879.4M
Annual profit (last year)$456.4M
Net profit margin51.93%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Uday Vijaykumar Baldota
Vice President &
Operations Head-Haifa
Itamar Karsenti
Corporate headquarters
Haifa Bay, Haifa

Forecasts